Longitudinal monitoring of somatic genetic alterations in circulating cell-free DNA during treatment with epidermal growth factor receptor-tyrosine kinase inhibitors.
Eiji IwamaKazuko SakaiNoriko HidakaKoji InoueAkiko FujiiNoriaki NakagakiKeiichi OtaRyo ToyozawaKoichi AzumaKeita NakatomiTaishi HaradaJunko HisasueShinya SakataTakayuki ShimoseJunji KishimotoYoichi NakanishiKazuto NishioIsamu OkamotoPublished in: Cancer (2019)
Liquid biopsy shows potential for prediction of EGFR-TKI efficacy and elucidation of clonal tumor evolution during targeted therapy.